[go: up one dir, main page]

NO20031204L - Procedures for Imaging and Diagnosis of Thrombus Using Nuclear Spin Tomography Using Particular Contrast Agents - Google Patents

Procedures for Imaging and Diagnosis of Thrombus Using Nuclear Spin Tomography Using Particular Contrast Agents

Info

Publication number
NO20031204L
NO20031204L NO20031204A NO20031204A NO20031204L NO 20031204 L NO20031204 L NO 20031204L NO 20031204 A NO20031204 A NO 20031204A NO 20031204 A NO20031204 A NO 20031204A NO 20031204 L NO20031204 L NO 20031204L
Authority
NO
Norway
Prior art keywords
thrombus
diagnosis
imaging
procedures
contrast agents
Prior art date
Application number
NO20031204A
Other languages
Norwegian (no)
Other versions
NO20031204D0 (en
Inventor
Stephan Schmitz
Mayk Kresse
Susanne Wagner
Original Assignee
Diagnostikforschung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst filed Critical Diagnostikforschung Inst
Publication of NO20031204D0 publication Critical patent/NO20031204D0/en
Publication of NO20031204L publication Critical patent/NO20031204L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/0263—Measuring blood flow using NMR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Signal Processing (AREA)
  • Epidemiology (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20031204A 2000-09-15 2003-03-17 Procedures for Imaging and Diagnosis of Thrombus Using Nuclear Spin Tomography Using Particular Contrast Agents NO20031204L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10046514A DE10046514A1 (en) 2000-09-15 2000-09-15 Process for imaging and diagnosis of thrombi using magnetic resonance imaging using particulate contrast media
PCT/EP2001/010233 WO2002022011A1 (en) 2000-09-15 2001-09-05 Method for pictorially depicting and diagnosing thrombi by means of nuclear spin tomography involving the use of particulate contrast agents

Publications (2)

Publication Number Publication Date
NO20031204D0 NO20031204D0 (en) 2003-03-17
NO20031204L true NO20031204L (en) 2003-03-17

Family

ID=7656910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031204A NO20031204L (en) 2000-09-15 2003-03-17 Procedures for Imaging and Diagnosis of Thrombus Using Nuclear Spin Tomography Using Particular Contrast Agents

Country Status (7)

Country Link
EP (1) EP1317208A1 (en)
JP (1) JP2004508123A (en)
AU (1) AU2002212207A1 (en)
DE (1) DE10046514A1 (en)
NO (1) NO20031204L (en)
TW (1) TWI239830B (en)
WO (1) WO2002022011A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10222481A1 (en) * 2002-05-22 2003-12-04 Eucro Europe Contract Res Gmbh Contrast agent for use in imaging
FR2861994A1 (en) * 2003-11-12 2005-05-13 Guerbet Sa Using coated magnetic oxide particles for diagnosis or treatment of diseases in which matrix metalloproteases are implicated e.g. atheromous plaque or cancers, do not include targeting agent
GB2439747A (en) 2006-07-03 2008-01-09 Uni Degli Studi Di Urbino Carl Delivery of contrasting agents for magnetic resonance imaging
CN103917658B (en) * 2011-07-13 2016-09-21 T2生物系统公司 For monitoring the NMR method that clot is formed
EP3087921A1 (en) * 2015-04-27 2016-11-02 Coronary Technologies SARL Computer-implemented method for identifying zones of stasis and stenosis in blood vessels

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
WO1994003501A1 (en) 1992-08-05 1994-02-17 Meito Sangyo Kabushiki Kaisha Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide
GB9401483D0 (en) 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds
DE19509694A1 (en) * 1995-03-08 1996-09-19 Schering Ag Use of magnetites to determine the perfusion of human tissue using MR diagnostics
AU727764B2 (en) 1996-08-05 2000-12-21 Schering Aktiengesellschaft Process for the production of contrast media for magnetic resonance tomography
AU4753997A (en) 1996-10-16 1998-05-11 Burnham Institute, The Magnetic resonance imaging of thrombi
DE19811349C1 (en) * 1998-03-16 1999-10-07 Siemens Ag Process for contrast substance tracing using medical imaging appts.
ES2334555T3 (en) * 1999-04-09 2010-03-12 Amag Pharmaceuticals, Inc. STAINLESS STEEL COATED IRON COATED IRON OXIDES.
EP1181571B1 (en) * 1999-05-21 2008-12-17 GE Healthcare AS Method of magnetic resonance imaging

Also Published As

Publication number Publication date
TWI239830B (en) 2005-09-21
WO2002022011A1 (en) 2002-03-21
EP1317208A1 (en) 2003-06-11
AU2002212207A1 (en) 2002-03-26
JP2004508123A (en) 2004-03-18
NO20031204D0 (en) 2003-03-17
DE10046514A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
NO20030860L (en) Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
FI990559A0 (en) Sample treatment procedure and diagnostic measuring apparatus
ITSV980052A0 (en) PATIENT BED OR SIMILAR, AND MACHINE, IN PARTICULAR FOR THE DETECTION OF NUCLEAR MAGNETIC RESONANCE IMAGING IN COMBINATION
NO20022592L (en) Compounds and Methods for the Treatment and Diagnosis of Chlamydia Infections
NO20024972D0 (en) Mixtures and Methods for Therapy and Diagnosis of Breast Cancer
DE69535509D1 (en) Medical diagnostic imaging system and procedure
WO1997036619A3 (en) Bioactivated diagnostic imaging contrast agents
NO996173L (en) Overhauser magnetic resonance imaging method comprising ex vivo polarization of an MRI contrast agent
RU2007131930A (en) TREATMENT AND DIAGNOSTIC OF DISEASES MEDIATED BY MACROPHAGES
EE200300005A (en) Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and apparatus
NO991688D0 (en) Manageable compositions and methods for magnetic resonance imaging
NO20016427D0 (en) Compositions and Methods for the Treatment of Diagnosis of Lung Cancer
DE19983769T1 (en) Ultrasonic method for medical diagnosis and system for switching elements
DE69727998D1 (en) Optimal diagnostic point detector for non-invasive diagnosis of blood components
NO20030714L (en) Mixtures and Methods for the Treatment and Diagnosis of HER-2 / NEU-Associated Malignancies
NO965454D0 (en) Diatrizoxy ester as X-ray contrast agents for imaging of blood and lymphatic system
NO971348D0 (en) Test unit for collection and examination of body fluid
DE60035240D1 (en) Marker for computed tomography and MRI imaging
IL130939A0 (en) Probe devices particularly useful for non-invasive detection of medical conditions
NO994932D0 (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
NO20032007D0 (en) Radiopharmaceuticals for the diagnosis of Alzheimer's disease
NO20002517L (en) Magnetic resonance imaging agents for the detection of physiological agents
GB0022341D0 (en) Method
NO20031204L (en) Procedures for Imaging and Diagnosis of Thrombus Using Nuclear Spin Tomography Using Particular Contrast Agents
WO2002023209A3 (en) Mri method involving the use of a hyperpolarized contrast agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application